Small milestone from Merck collaboration that was not even on the radar. Pity BNO only gets about 5% to the payment.........
What else is there to provide more pleasant surprises?????
Selling and buying at 29-30c seems never ending - so either CVC and Freedman are just churning in order to confuse and depress the share price - or someone has been an ongoing seller and another party or parties have been ongoing buyers.
A current Top 40 shareholder list would be nice..........
Until the share register is stabilised by the removal of CVC and Freedman, the stock is not going anywhere I am afraid................
Very disappointed that the company has not managed to engage and to resolve this problem by now.
Does anyone else have any ideas on where the stock is coming from or going to?????
It is still cheap as chips but more news on commercialisation progress in needed - in spite of great clinical progress in order to get the price moving in the right direction again.
A progress report on negotiations on main drug candidates would be kind of helpful.
I remain a BNO bull, but...................DYOR
BNO Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held
